| Primary |
| Idiopathic Thrombocytopenic Purpura |
87.9% |
| Prophylaxis Against Rh Isoimmunisation |
5.2% |
| Thrombocytopenia |
1.7% |
| Autoimmune Thrombocytopenia |
1.1% |
| Immune Thrombocytopenic Purpura |
1.1% |
| Platelet Count Decreased |
1.1% |
| Abortion Threatened |
0.6% |
| Foetal-maternal Haemorrhage |
0.6% |
| Thrombocytopenic Purpura |
0.6% |
|
| Haemolysis |
35.5% |
| Pyrexia |
8.1% |
| Haemoglobin Decreased |
4.8% |
| Intravascular Haemolysis |
4.8% |
| Tachycardia |
4.8% |
| Vomiting |
4.8% |
| Hepatitis C Virus Test Positive |
4.0% |
| Headache |
3.2% |
| Infusion Related Reaction |
3.2% |
| Renal Failure Acute |
3.2% |
| Thrombocytopenia |
3.2% |
| Tremor |
3.2% |
| Haemolytic Transfusion Reaction |
2.4% |
| Hepatitis C |
2.4% |
| Overdose |
2.4% |
| Oxygen Saturation Decreased |
2.4% |
| Pain In Extremity |
2.4% |
| Chills |
1.6% |
| Extravascular Haemolysis |
1.6% |
| Malaise |
1.6% |
|
| Secondary |
| Idiopathic Thrombocytopenic Purpura |
74.0% |
| Prophylaxis Against Rh Isoimmunisation |
19.2% |
| Foetal-maternal Haemorrhage |
4.1% |
| Thrombocytopenic Purpura |
2.7% |
|
| Hepatitis C Virus Test Positive |
28.3% |
| Oxygen Saturation Decreased |
7.5% |
| Hepatitis C |
5.7% |
| Overdose |
5.7% |
| Pallor |
5.7% |
| Bilirubin Conjugated Increased |
3.8% |
| Chills |
3.8% |
| Haemoglobin Decreased |
3.8% |
| Hepatitis B Positive |
3.8% |
| Infusion Related Reaction |
3.8% |
| Maternal Exposure During Delivery |
3.8% |
| Pain In Extremity |
3.8% |
| Pyrexia |
3.8% |
| Septic Shock |
3.8% |
| Vasculitis |
3.8% |
| Blood Urine Present |
1.9% |
| Flushing |
1.9% |
| Haemolysis |
1.9% |
| Hepatitis B Surface Antigen Positive |
1.9% |
| Lymphoma |
1.9% |
|
| Concomitant |
| Idiopathic Thrombocytopenic Purpura |
76.8% |
| Thrombocytopenia |
5.5% |
| Product Used For Unknown Indication |
4.4% |
| Premedication |
2.2% |
| Autoimmune Thrombocytopenia |
1.7% |
| Sneezing |
1.7% |
| Herpes Zoster |
1.1% |
| Neutropenia |
1.1% |
| Blood Cholesterol Increased |
0.6% |
| Bone Marrow Disorder |
0.6% |
| Constipation |
0.6% |
| Deep Vein Thrombosis |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Muscle Disorder |
0.6% |
| Off Label Use |
0.6% |
| Pain |
0.6% |
| Post Procedural Haemorrhage |
0.6% |
| Smoking Cessation Therapy |
0.6% |
|
| Therapeutic Response Decreased |
23.5% |
| Drug Ineffective |
12.2% |
| Thrombocytopenia |
11.2% |
| Platelet Count Decreased |
5.1% |
| Bone Marrow Disorder |
4.1% |
| Death |
4.1% |
| Gastrointestinal Haemorrhage |
4.1% |
| Haematochezia |
4.1% |
| Myelodysplastic Syndrome |
4.1% |
| Urticaria |
4.1% |
| Biopsy Bone Marrow Abnormal |
3.1% |
| Pulmonary Embolism |
3.1% |
| Vision Blurred |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Embolism |
2.0% |
| Hip Arthroplasty |
2.0% |
| Pain In Extremity |
2.0% |
| Platelet Count Abnormal |
2.0% |
| Vomiting |
2.0% |
| Abdominal Pain |
1.0% |
|
